APTISSEN ITALIA

Aptissen Italia is the Italian subsidiary of Aptissen, a Swiss-based life sciences company specializing in the development of injectable biopolymers for orthopedics and ophthalmology. The company's core expertise lies in its proprietary VA Technology, which utilizes a unique combination of high-molecular-weight hyaluronic acid and high concentrations of sorbitol to treat osteoarthritis. Its lead product, Synolis VA, is a visco-antalgic injection designed to provide rapid pain relief and restore joint mobility. Aptissen also offers a range of ophthalmic products, including viscoelastics for cataract surgery and glaucoma drainage devices. In 2024, the Aptissen group was acquired by Laboratoires Théa, strengthening its global position in the eye care and injectable medical device markets.